ArticleJournal of clinical tuberculosis and other mycobacterial diseases2026
Treatment outcomes among patients with mycobacterial blood stream infection in a tertiary hospital:a retrospective study form 2019 to 2023.
Article in Journal of clinical tuberculosis and other mycobacterial diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mycobacteria are rare causes of blood stream infections (BSI). Mycobacterial BSI is associated with a significantly increased risk of early death compared with other bacterial blood infectious diseases. Clinical characteristics and mortality rate of different Mycobacteria BSI remain unclear. Methods: A retrospective study of patients with positive mycobacterial blood cultures hospitalized between January 1, 2019, and June 30, 2023, at Shenzhen Third People's Hospital, a 1500-bed tertiary university-affiliated hospital in southern China, was performed. Clinical characteristics and mortality rate of patients with different Mycobacteria BSI were reviewed and analyzed. Results: Forty-one hospitalized patients with positive mycobacterium blood cultures were identified. Of the 41 participants, 37 (90.2 %) were newly diagnosed with HIV/AIDS. 7 (17.1 %) BSI was caused by Conclusion: The mortality rate of patients with mycobacterial BSI is high. Mycobacterial BSI occur mostly in severely ill patients with HIV/AIDS. TB-BSI was associated with a higher mortality rate compared to NTM-BSI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.